Evidence map›Paper›PMID 38110339›Full record

ArticleCell death & disease2023

Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation.

Valentina Casella, Eva Domenjo-Vila, Anna Esteve-Codina, Mireia Pedragosa, Paula Cebollada Rica, Enric Vidal, Ivan de la Rubia, Cristina López-Rodríguez, Gennady Bocharov, Jordi Argilaguet and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Exploring CD169Vaccines · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Valentina CasellaInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain.
Eva Domenjo-VilaInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain.ORCID 0000-0003-0678-4478
Anna Esteve-CodinaCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, 08028, Barcelona, Spain.ORCID 0000-0003-0361-2873
Mireia PedragosaInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain.
Paula Cebollada RicaInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain.ORCID 0000-0003-3246-7353
Enric VidalUnitat mixta d'Investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193, Bellaterra, Catalonia, Spain.ORCID 0000-0002-4965-3286
Ivan de la RubiaUniversitat Pompeu Fabra (UPF), 08003, Barcelona, Spain.
Cristina López-RodríguezImmunology Unit, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain.
Gennady BocharovMarchuk Institute of Numerical Mathematics, Russian Academy of Sciences, 119333, Moscow, Russia.ORCID 0000-0002-5049-0656
Jordi ArgilaguetInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain. jordi.argilaguet@irta.cat.
Andreas MeyerhansInfection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003, Barcelona, Spain. andreas.meyerhans@upf.edu.ORCID 0000-0003-0620-5317
Universitat Pompeu Fabra · ESUniversitat Autònoma de Barcelona · ESAustralian National University · AUInstitució Catalana de Recerca i Estudis Avançats · ESRussian Academy of Sciences · RU

Funding

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) AEI (CEX2018-000792-M)Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PT17/0009/0019Russian Science Foundation (RSF) 23-11-0016
6 · The paper itself

Abstract

Acute infection and chronic infection are the two most common fates of pathogenic virus infections. While several factors that contribute to these fates are described, the critical control points and the mechanisms that underlie infection fate regulation are incompletely understood. Using the acute and chronic lymphocytic choriomeningitis virus (LCMV) infection model of mice, we find that the early dynamic pattern of the IFN-I response is a differentiating trait between both infection fates. Acute-infected mice generate a 2-wave IFN-I response while chronic-infected mice generate only a 1-wave response. The underlying cause is a temporal difference in CD8 T cell-mediated killing of splenic marginal zone CD169+ macrophages. It occurs later in acute infection and thus enables CD169+ marginal zone macrophages to produce the 2nd IFN-I wave. This is required for subsequent immune events including induction of inflammatory macrophages, generation of effector CD8+ T cells and virus clearance. Importantly, these benefits come at a cost for the host in the form of spleen fibrosis. Due to an earlier marginal zone destruction, these ordered immune events are deregulated in chronic infection. Our findings demonstrate the critical importance of kinetically well-coordinated sequential immune events for acute infection control and highlights that it may come at a cost for the host organism.

Indexed as

Lymphocytic ChoriomeningitisAnimalsCD8-Positive T-LymphocytesLymphocytic choriomeningitis virusMacrophagesMiceMice, Inbred C57BLPersistent Infection

Identifiers

PMID38110339
PMCPMC10728219
OpenAlexW4389862087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.